Projekte unter der Sponsorschaft der AIO-Studien-gGmbH

Kopf-Hals-Tumoren

AIO-KHT-0115 A randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with head and neck cancers (ELDORANDO)